Literature DB >> 22547706

NLRC4 inflammasome-mediated production of IL-1β modulates mucosal immunity in the lung against gram-negative bacterial infection.

Shanshan Cai1, Sanjay Batra, Nobuko Wakamatsu, Pal Pacher, Samithamby Jeyaseelan.   

Abstract

Bacterial flagellin is critical to mediate NLRC4 inflammasome-dependent caspase-1 activation. However, Shigella flexneri, a nonflagellated bacterium, and a flagellin (fliC) knockout strain of Pseudomonas aeruginosa are known to activate NLRC4 in bone marrow-derived macrophages. Furthermore, the flagellin-deficient fliC strain of P. aeruginosa was used in a mouse model of peritonitis to show the requirement of NLRC4. In a model of pulmonary P. aeruginosa infection, flagellin was shown to be essential for the induction of NLRC4-dependent caspase-1 activation. Moreover, in all P. aeruginosa studies, IL-1β production was attenuated in NLRC4(-/-) mice; however, the role of IL-1β in NLRC4-mediated innate immunity in the lungs against a nonflagellated bacterium was not explored. In this article, we report that NLRC4 is important for host survival and bacterial clearance, as well as neutrophil-mediated inflammation in the lungs following Klebsiella pneumoniae infection. NLRC4 is essential for K. pneumoniae-induced production of IL-1β, IL-17A, and neutrophil chemoattractants (keratinocyte cell-derived chemokines, MIP-2, and LPS-induced CXC chemokines) in the lungs. NLRC4 signaling in hematopoietic cells contributes to K. pneumoniae-induced lung inflammation. Furthermore, exogenous IL-1β, but not IL-18 or IL-17A, partially rescued survival, neutrophil accumulation, and cytokine/chemokine expression in the lungs of NLRC4(-/-) mice following infectious challenge. Furthermore, IL-1R1(-/-) mice displayed a decrease in neutrophilic inflammation in the lungs postinfection. Taken together, these findings provide novel insights into the role of NLRC4 in host defense against K. pneumoniae infection.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22547706      PMCID: PMC3358410          DOI: 10.4049/jimmunol.1200195

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  86 in total

1.  Chemokines integrate JAK/STAT and G-protein pathways during chemotaxis and calcium flux responses.

Authors:  Silvia F Soriano; Antonio Serrano; Patricia Hernanz-Falcón; Ana Martín de Ana; María Monterrubio; Carlos Martínez; J Miguel Rodríguez-Frade; Mario Mellado
Journal:  Eur J Immunol       Date:  2003-05       Impact factor: 5.532

2.  The role of bacterial interference in the increased prevalence of oropharyngeal gram-negative bacilli among alcoholics and diabetics.

Authors:  P A Mackowiak; R M Martin; J W Smith
Journal:  Am Rev Respir Dis       Date:  1979-09

3.  Neutrophils produce interleukin 17A (IL-17A) in a dectin-1- and IL-23-dependent manner during invasive fungal infection.

Authors:  Jessica L Werner; Melissa A Gessner; Lauren M Lilly; Michael P Nelson; Allison E Metz; Dawn Horn; Chad W Dunaway; Jessy Deshane; David D Chaplin; Casey T Weaver; Gordon D Brown; Chad Steele
Journal:  Infect Immun       Date:  2011-08-01       Impact factor: 3.441

4.  Critical role of signaling through IL-1 receptor for development of arthritis and sepsis during Staphylococcus aureus infection.

Authors:  Olof H Hultgren; Lena Svensson; Andrej Tarkowski
Journal:  J Immunol       Date:  2002-05-15       Impact factor: 5.422

5.  CXCL1 regulates pulmonary host defense to Klebsiella Infection via CXCL2, CXCL5, NF-kappaB, and MAPKs.

Authors:  Shanshan Cai; Sanjay Batra; Sergio A Lira; Jay K Kolls; Samithamby Jeyaseelan
Journal:  J Immunol       Date:  2010-10-11       Impact factor: 5.422

6.  Identification of bacterial muramyl dipeptide as activator of the NALP3/cryopyrin inflammasome.

Authors:  Fabio Martinon; Laetitia Agostini; Etienne Meylan; Jürg Tschopp
Journal:  Curr Biol       Date:  2004-11-09       Impact factor: 10.834

7.  Plasmid comparison and molecular analysis of Klebsiella pneumoniae harbouring bla(KPC) from New York City and Toronto.

Authors:  L F Mataseje; D A Boyd; B M Willey; N Prayitno; N Kreiswirth; A Gelosia; S M Poutanen; D E Low; S G Jenkins; K Katz; M R Mulvey
Journal:  J Antimicrob Chemother       Date:  2011-03-15       Impact factor: 5.790

8.  Innate immune detection of the type III secretion apparatus through the NLRC4 inflammasome.

Authors:  Edward A Miao; Dat P Mao; Natalya Yudkovsky; Richard Bonneau; Cynthia G Lorang; Sarah E Warren; Irina A Leaf; Alan Aderem
Journal:  Proc Natl Acad Sci U S A       Date:  2010-02-01       Impact factor: 11.205

9.  A mutation in the Nlrp3 gene causing inflammasome hyperactivation potentiates Th17 cell-dominant immune responses.

Authors:  Guangxun Meng; Fuping Zhang; Ivan Fuss; Atsushi Kitani; Warren Strober
Journal:  Immunity       Date:  2009-06-04       Impact factor: 31.745

10.  Redundant roles for inflammasome receptors NLRP3 and NLRC4 in host defense against Salmonella.

Authors:  Petr Broz; Kim Newton; Mohamed Lamkanfi; Sanjeev Mariathasan; Vishva M Dixit; Denise M Monack
Journal:  J Exp Med       Date:  2010-07-05       Impact factor: 14.307

View more
  62 in total

Review 1.  Innate Immune Signaling Activated by MDR Bacteria in the Airway.

Authors:  Dane Parker; Danielle Ahn; Taylor Cohen; Alice Prince
Journal:  Physiol Rev       Date:  2016-01       Impact factor: 37.312

Review 2.  Regulation of inflammasome activation.

Authors:  Si Ming Man; Thirumala-Devi Kanneganti
Journal:  Immunol Rev       Date:  2015-05       Impact factor: 12.988

3.  The inflammasome adaptor ASC contributes to multiple innate immune processes in the resolution of otitis media.

Authors:  Arwa Kurabi; Jasmine Lee; Chelsea Wong; Kwang Pak; Hal M Hoffman; Allen F Ryan; Stephen I Wasserman
Journal:  Innate Immun       Date:  2014-03-20       Impact factor: 2.680

4.  High expression level of interleukin-1β is correlated with poor prognosis and PD-1 expression in patients with lung adenocarcinoma.

Authors:  X Ding; J Zhang; M Shi; D Liu; L Zhang; R Zhang; B Su; K Ai
Journal:  Clin Transl Oncol       Date:  2020-05-29       Impact factor: 3.405

5.  Inflammasome Activity in Non-Microbial Lung Inflammation.

Authors:  Jennifer L Ather; Rebecca A Martin; Karina Ckless; Matthew E Poynter
Journal:  J Environ Immunol Toxicol       Date:  2014-09-20

6.  Allergic airway inflammation decreases lung bacterial burden following acute Klebsiella pneumoniae infection in a neutrophil- and CCL8-dependent manner.

Authors:  Daniel E Dulek; Dawn C Newcomb; Kasia Goleniewska; Jaqueline Cephus; Weisong Zhou; Sara Reiss; Shinji Toki; Fei Ye; Rinat Zaynagetdinov; Taylor P Sherrill; Timothy S Blackwell; Martin L Moore; Kelli L Boyd; Jay K Kolls; R Stokes Peebles
Journal:  Infect Immun       Date:  2014-06-23       Impact factor: 3.441

7.  Distinct contributions of interleukin-1α (IL-1α) and IL-1β to innate immune recognition of Pseudomonas aeruginosa in the lung.

Authors:  Khatoun Al Moussawi; Barbara I Kazmierczak
Journal:  Infect Immun       Date:  2014-07-28       Impact factor: 3.441

8.  N-acetylcysteine protects murine alveolar type II cells from cigarette smoke injury in a nuclear erythroid 2-related factor-2-independent manner.

Authors:  Elise M Messier; Brian J Day; Karim Bahmed; Steven R Kleeberger; Rubin M Tuder; Russell P Bowler; Hong Wei Chu; Robert J Mason; Beata Kosmider
Journal:  Am J Respir Cell Mol Biol       Date:  2013-05       Impact factor: 6.914

Review 9.  Pathogenesis of Rickettsial Diseases: Pathogenic and Immune Mechanisms of an Endotheliotropic Infection.

Authors:  Abha Sahni; Rong Fang; Sanjeev K Sahni; David H Walker
Journal:  Annu Rev Pathol       Date:  2018-08-27       Impact factor: 23.472

10.  Deciphering tissue-induced Klebsiella pneumoniae lipid A structure.

Authors:  Enrique Llobet; Verónica Martínez-Moliner; David Moranta; Käthe M Dahlström; Verónica Regueiro; Anna Tomás; Victoria Cano; Camino Pérez-Gutiérrez; Christian G Frank; Helena Fernández-Carrasco; José Luis Insua; Tiina A Salminen; Junkal Garmendia; José A Bengoechea
Journal:  Proc Natl Acad Sci U S A       Date:  2015-11-02       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.